OBJECTIVE: We reevaluated the Action for Health in Diabetes (Look AHEAD) intervention, incorporating diabetes subgroups, to identify whether intensive lifestyle intervention (ILI) is associated with differential risk for cardiovascular disease (CVD) by diabetes subgroup. RESEARCH DESIGN AND METHODS: In the Look AHEAD trial, 5,145 participants, aged 45-76 years, with type 2 diabetes (T2D) and overweight or obesity were randomly assigned to 10 years of ILI or a control condition of diabetes support and education. The ILI focused on weight loss through decreased caloric intake and increased physical activity. To characterize diabetes subgroups, we applied k-means clustering to data on age of diabetes diagnosis, BMI, waist circumference, and glycated hemoglobin. We examined whether relative intervention effects on the trial's prespecified CVD outcomes varied among diabetes subgroups. RESULTS: We characterized four subgroups related to older age at diabetes onset (42% of sample), poor glucose control (14%), severe obesity (24%), and younger age at diabetes onset (20%). We observed interactions (all P < 0.05) between intervention and diabetes subgroups for three separate composite cardiovascular outcomes. Randomization to ILI was associated with increased risk for each cardiovascular outcome only among the poor-glucose-control subgroup (hazard ratio >1.32). Among the three other diabetes subgroups, ILI was not associated with increased risk for CVD. CONCLUSIONS: Among overweight and obese adults with T2D, a lifestyle intervention was associated with differential risk for CVD that was dependent on diabetes subgroup. Diabetes subgroups may be important to identify the patients who would achieve benefit and avoid harm from an ILI.
OBJECTIVE: We reevaluated the Action for Health in Diabetes (Look AHEAD) intervention, incorporating diabetes subgroups, to identify whether intensive lifestyle intervention (ILI) is associated with differential risk for cardiovascular disease (CVD) by diabetes subgroup. RESEARCH DESIGN AND METHODS: In the Look AHEAD trial, 5,145 participants, aged 45-76 years, with type 2 diabetes (T2D) and overweight or obesity were randomly assigned to 10 years of ILI or a control condition of diabetes support and education. The ILI focused on weight loss through decreased caloric intake and increased physical activity. To characterize diabetes subgroups, we applied k-means clustering to data on age of diabetes diagnosis, BMI, waist circumference, and glycated hemoglobin. We examined whether relative intervention effects on the trial's prespecified CVD outcomes varied among diabetes subgroups. RESULTS: We characterized four subgroups related to older age at diabetes onset (42% of sample), poor glucose control (14%), severe obesity (24%), and younger age at diabetes onset (20%). We observed interactions (all P < 0.05) between intervention and diabetes subgroups for three separate composite cardiovascular outcomes. Randomization to ILI was associated with increased risk for each cardiovascular outcome only among the poor-glucose-control subgroup (hazard ratio >1.32). Among the three other diabetes subgroups, ILI was not associated with increased risk for CVD. CONCLUSIONS: Among overweight and obese adults with T2D, a lifestyle intervention was associated with differential risk for CVD that was dependent on diabetes subgroup. Diabetes subgroups may be important to identify the patients who would achieve benefit and avoid harm from an ILI.
Authors: Mark A Espeland; Sarah A Gaussoin; Judy Bahnson; Elizabeth M Vaughan; William C Knowler; Felicia R Simpson; Helen P Hazuda; Karen C Johnson; Medha N Munshi; Mace Coday; Xavier Pi-Sunyer Journal: J Am Geriatr Soc Date: 2020-07-17 Impact factor: 5.562
Authors: Oana P Zaharia; Klaus Strassburger; Alexander Strom; Gidon J Bönhof; Yanislava Karusheva; Sofia Antoniou; Kálmán Bódis; Daniel F Markgraf; Volker Burkart; Karsten Müssig; Jong-Hee Hwang; Olof Asplund; Leif Groop; Emma Ahlqvist; Jochen Seissler; Peter Nawroth; Stefan Kopf; Sebastian M Schmid; Michael Stumvoll; Andreas F H Pfeiffer; Stefan Kabisch; Sergey Tselmin; Hans U Häring; Dan Ziegler; Oliver Kuss; Julia Szendroedi; Michael Roden Journal: Lancet Diabetes Endocrinol Date: 2019-07-22 Impact factor: 32.069
Authors: Thomas A Wadden; Delia Smith West; Linda Delahanty; John Jakicic; Jack Rejeski; Don Williamson; Robert I Berkowitz; David E Kelley; Christine Tomchee; James O Hill; Shiriki Kumanyika Journal: Obesity (Silver Spring) Date: 2006-05 Impact factor: 5.002
Authors: Donna H Ryan; Mark A Espeland; Gary D Foster; Steven M Haffner; Van S Hubbard; Karen C Johnson; Steven E Kahn; William C Knowler; Susan Z Yanovski Journal: Control Clin Trials Date: 2003-10
Authors: Xavier Pi-Sunyer; George Blackburn; Frederick L Brancati; George A Bray; Renee Bright; Jeanne M Clark; Jeffrey M Curtis; Mark A Espeland; John P Foreyt; Kathryn Graves; Steven M Haffner; Barbara Harrison; James O Hill; Edward S Horton; John Jakicic; Robert W Jeffery; Karen C Johnson; Steven Kahn; David E Kelley; Abbas E Kitabchi; William C Knowler; Cora E Lewis; Barbara J Maschak-Carey; Brenda Montgomery; David M Nathan; Jennifer Patricio; Anne Peters; J Bruce Redmon; Rebecca S Reeves; Donna H Ryan; Monika Safford; Brent Van Dorsten; Thomas A Wadden; Lynne Wagenknecht; Jacqueline Wesche-Thobaben; Rena R Wing; Susan Z Yanovski Journal: Diabetes Care Date: 2007-03-15 Impact factor: 19.112
Authors: Cora E Lewis; John P Bantle; Alain G Bertoni; George Blackburn; Frederick L Brancati; George A Bray; Lawrence J Cheskin; Jeffrey M Curtis; Caitlin Egan; Mary Evans; John P Foreyt; Siran Ghazarian; Bethany Barone Gibbs; Stephen P Glasser; Edward W Gregg; Helen P Hazuda; Louise Hesson; James O Hill; Edward S Horton; Van S Hubbard; John M Jakicic; Robert W Jeffery; Karen C Johnson; Steven E Kahn; Abbas E Kitabchi; Dalane Kitzman; William C Knowler; Edward Lipkin; Sara Michaels; Maria G Montez; David M Nathan; Ebenezer Nyenwe; Jennifer Patricio; Anne Peters; Xavier Pi-Sunyer; Henry Pownall; David M Reboussin; Donna H Ryan; Thomas A Wadden; Lynne E Wagenknecht; Holly Wyatt; Rena R Wing; Susan Z Yanovski Journal: Obesity (Silver Spring) Date: 2020-01-03 Impact factor: 5.002
Authors: John M Dennis; Beverley M Shields; William E Henley; Angus G Jones; Andrew T Hattersley Journal: Lancet Diabetes Endocrinol Date: 2019-04-29 Impact factor: 44.867
Authors: Jiexun Wang; Jian-Jun Liu; Resham L Gurung; Sylvia Liu; Janus Lee; Yiamunaa M; Keven Ang; Yi Ming Shao; Justin I-Shing Tang; Peter I Benke; Federico Torta; Markus R Wenk; Subramaniam Tavintharan; Wern Ee Tang; Chee Fang Sum; Su Chi Lim Journal: Diabetologia Date: 2022-06-28 Impact factor: 10.460